Erythritol: Popular Sweetener Linked to Stroke & Heart Risks

Erythritol, a widely used sugar alcohol, is increasingly under scrutiny as emerging research suggests it may not be the harmless sugar substitute it was once considered. Recent studies indicate a potential link between erythritol consumption and an increased risk of cardiovascular events, including heart attack and stroke, as well as potential damage to the brain’s protective barrier.

Erythritol (E968) is a naturally occurring, nearly calorie-free sweetener found in small amounts in fruits like melons and grapes and in fermented foods such as cheese and wine. It’s also manufactured and commonly added to a variety of products, including candies, chewing gum, chocolate, and sugar-free beverages. While often marketed as a healthy alternative to sugar, growing evidence suggests a more complex picture.

Researchers at the University of Colorado have discovered that erythritol may compromise the integrity of cells within the blood-brain barrier, a crucial protective mechanism for the brain. This barrier carefully regulates the passage of substances into the brain, shielding it from harmful elements while allowing essential nutrients to enter. Damage to this barrier could have serious implications for brain health and increase vulnerability to neurological events.

In a laboratory study, researchers exposed blood-brain barrier cells to erythritol concentrations comparable to those achieved after consuming a soft drink sweetened with the compound. They observed a cascade of cellular damage, potentially making the brain more susceptible to blood clot formation – a leading cause of stroke. This damage stems from a process called oxidative stress, where erythritol triggers an influx of harmful free radicals while simultaneously reducing the body’s natural antioxidant defenses. The combined effect impairs cellular function and, in some cases, leads to cell death.

Beyond cellular damage, the study revealed that erythritol disrupts the delicate balance of blood vessel regulation. Healthy blood vessels dynamically adjust blood flow based on organ needs, widening to deliver more blood during activity and constricting when less is required. This regulation relies on two key molecules: nitric oxide, which promotes blood vessel relaxation, and endothelin-1, which causes constriction. The research showed that erythritol interfered with this system, reducing nitric oxide production while simultaneously increasing endothelin-1 levels, potentially leading to dangerously constricted blood vessels and reduced blood flow to the brain.

These findings build upon previous research linking erythritol to cardiovascular risks. A study published in March 2023 by the National Institutes of Health (NIH) found that higher blood levels of erythritol were associated with an increased risk of heart attack and stroke. This research, led by Dr. Stanley Hazen at the Cleveland Clinic, examined data from over 3,000 individuals in the U.S. And Europe and revealed a correlation between elevated erythritol levels and adverse cardiovascular events.

The NIH study also noted that erythritol levels achieved through typical consumption as a sweetener are often more than 1,000 times higher than those naturally found in foods. Erythritol falls into a category of ingredients called “sugar alcohols,” which are not always individually listed on nutrition labels, making it difficult for consumers to track their intake.

Further research, published in February 2023 in Nature Medicine, demonstrated that erythritol can enhance platelet reactivity and promote thrombosis, the formation of blood clots. In a small pilot study, researchers found that consuming erythritol led to sustained increases in plasma erythritol levels, exceeding thresholds associated with heightened platelet reactivity and increased thrombosis potential.

It’s important to note that the University of Colorado study involved experiments conducted on isolated cells in a laboratory setting, rather than on complete blood vessels within a living organism. This means the cellular behavior observed in the study may not perfectly replicate the complex interactions within the human body. However, the findings raise significant concerns and warrant further investigation.

While the research is ongoing and more studies are needed to fully understand the long-term effects of erythritol, these findings suggest that consumers should be aware of the potential risks associated with high intake of this widely used sweetener. Individuals with pre-existing cardiovascular conditions or risk factors may want to discuss their erythritol consumption with their healthcare provider.

Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. This proves essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.